Gefährliches Souvenier - Rocky Mountain Spotted Fever

Zusammenfassung

Rickettsiosen gehören zu einer weltweit vorkommenden Gruppe von Anthropozoonosen. Rickettsien sind Verursacher des Rocky Mountain Spotted Fever und der Rickettsienpocken. Aufgrund der Unspezifität und Variabilität ihrer Symptome sowie der relativen Unbekanntheit in Deutschland können sie die Diagnosestellung und Therapie bei Reisenden aus Endemiegebieten verzögern. Dies führt im Falle des Rocky Mountain Spotted Fever zu einer deutlichen Prognoseverschlechterung und birgt die Gefahr von multiplen Organschäden wie Enzephalopathien, Lungenödem und Störungen von Elektrolythaushalt und Blutgerinnung. Aufgrund des zunehmenden Reiseverkehrs in Endemiegebiete und des Nachweises neuer Rickettsiosen in Europa muss der deutsche Arzt für diese Erkrankungen sensibilisiert werden, um adäquat und frühzeitig (be)handeln zu können. Die vorliegende Kasuistik beschreibt den siebentägigen Krankheitsverlauf einer letztlich ungeklärten Rickettsiose bei zwei deutschen Touristen in Toronto, Ontario, Kanada.

Abstract

Rickettsioses belong to a group of world wide occurring anthropozoonoses causing both rocky mountain spotted fever and rickettsialpox. Unspecifity and variety of symptoms as well as unawareness of the disease in German medical practice may lead to underdiagnose in repatriates and tourists from endemic areas. Prolonged incertitude in diagnosis and delayed therapy in the case of Rocky Mountain Spotted Fever may contribute to a worse outcome and holds risk of multiple organ dysfunction, such as encephalopathy, pulmonary edema, electrolyte disturbances and impairments within the coagulation system. In view of increased tourist travel in endemic areas and detection of new rickettsioses in Europe, German physicians have to be sensitized for rickettsial infections to react early and adequately. The here reported case demonstrates a seven-day course of disease of two German tourists traveling to Toronto, Ontario, Canada.

Rickettsiose - Rocky Mountain Spotted Fever - Anthropozoonose - Rickettsienpocken - RMSF

Rickettsiosis - Rocky Mountain Spotted Fever - Anthropozoonose - Rickettsialpox - RMSF

Literatur

• 1 Perlman SJ, Hunter MS, Zchori-Fein E. The emerging diversity of rickettsia.  Proc Biol Sci. 2006;  273 ((1598)) 2097-2106
• 2 Stanczak J. The occurrence of spotted fever group (SFG) rickettsiae in ixodes ricinus ticks (acari: ixodidae) in northern poland.  Ann N Y Acad Sci. 2006;  1078 512-514
• 3 http://www.cdc.gov In: centers of disease control and prevention
• 4 Chapman AS, Bakken JS, Folk SM, Paddock CD, Bloch KC, Krusell A. et al . Diagnosis and management of tickborne rickettsial diseases: rocky mountain spotted fever, ehrlichioses, and anaplasmosis - united States: a practical guide for physicians and other health-care and public health professionals.  MMWR Recomm Rep. 2006;  55 ((RR-4)) 1-27
• 5 Silber JL. Rocky mountain spotted fever.  Clin Dermatol. 1996;  14 ((3)) 245-258
• 6 Bassetti S. Rickettsioses of the spotted fever-group.  Internist (Berl). 2004;  45 ((6)) 669-676
• 7 Raoult D, Roux V. Rickettsioses as paradigms of new or emerging infectious diseases.  Clin Microbiol Rev. 1997;  10 ((4)) 694-719
• 8 Lacz NL, Schwartz RA, Kapila R. Rocky mountain spotted fever.  J Eur Acad Dermatol Venereol. 2006;  20 ((4)) 411-417
• 9 Dalton MJ, Clarke MJ, Holman RC, Krebs JW, Fishbein DB, Olson JG. et al . National surveillance for rocky mountain spotted fever, 1981-1992: epidemiologic summary and evaluation of risk factors for fatal outcome.  Am J Trop Med Hyg. 1995;  52 ((5)) 405-413
• 10 Fitzpatrick TBEA, Wolff K, Freeberg IM, Austen KF. Dermatolgy in general medicine. 4th ed. New York: McGraw - Hill 1993
• 11 DuPont HL, Hornick RB, Dawkins AT, Heiner GG, Fabrikant IB, Wisseman Jr CL. et al . Rocky mountain spotted fever: a comparative study of the active immunity induced by inactivated and viable pathogenic rickettsia rickettsii.  J Infect Dis. 1973;  128 ((3)) 340-344
• 12 Walker TS, Hoover CS. Rickettsial effects on leukotriene and prostaglandin secretion by mouse polymorphonuclear leukocytes.  Infect Immun. 1991;  59 ((1)) 351-356
• 13 Helmick CG, Bernard KW, D’Angelo LJ. Rocky mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases.  J Infect Dis. 1984;  150 ((4)) 480-488
• 14 Wilfert CM, MacCormack JN, Kleeman K, Philip RN, Austin E, Dickinson V. et al . Epidemiology of rocky mountain spotted fever as determined by active surveillance.  J Infect Dis. 1984;  150 ((4)) 469-479
• 15 Remington JSSM. Current clinical Topics in infectious Diseases. New York: Churchill Livingstone 1995
• 16 Sexton DJ, Corey GR. Rocky mountain “spotless” and “almost spot-less” fever: a wolf in sheep's clothing.  Clin Infect Dis. 1992;  15 ((3)) 439-448
• 17 http://www.charite.de/tropenmedizin/
• 18 http://www.bni.uni-hamburg.de/
• 19 http://www.kms.mhn.de/1440.html
• 20 Archibald LK, Sexton DJ. Long-term sequelae of rocky mountain spotted fever.  Clin Infect Dis. 1995;  20 ((5)) 1122-1125
• 21 Carroll JF, Kramer M. Winter activity of ixodes scapularis (acari: ixodidae) and the operation of deer-targeted tick control devices in maryland.  J Med Entomol. 2003;  40 ((2)) 238-244
• 22 Taylor JP, Istre GR, MacChesney TC. The epidemiology of rocky mountain spotted fever in arkansas, oklahoma, and texas, 1981 through 1985.  Am J Epidemiol. 1988;  127 ((6)) 1295-1301
• 23 Salgo MP, Telzak EE, Currie B, Perlman DC, Litman N, Levi M. et al . A focus of rocky mountain spotted fever within new york city.  N Engl J Med. 1988;  318 ((21)) 1345-1348
• 24 Brouqui P, Bacellar F, Baranton G, Birtles RJ, Bjoersdorff A, Blanco JR. et al . Guidelines for the diagnosis of tick-borne bacterial diseases in europe.  Clin Microbiol Infect. 2004;  10 ((12)) 1108-1132

Korrespondenzadresse